Aims and Scope of Journal of Drug Targeting
Journal of Drug Targeting is a peer-reviewed medical journal published by Informa that covers research on all aspects of drug delivery and drug targeting for molecular and macromolecular drugs. The editor in chief is Saghir Akhtar (College of Medicine, Qatar University). Less
Key Metrics
CiteScore 

8.8
Eigenfactor 

0.001 - 0.005
Impact Factor 

< 5
SJR 

Q1Pharmaceutical Science

SNIP 

0.85
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Drug Targeting
Journal of Drug Targeting Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Drug Targeting ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Drug Targeting
Tubulin as a Well-Established Yet Underexploited Target: New Opportunities for Drugs Repurposing?
- 29 Jun 2026
- Journal of drug targeting
Physcion-loaded, folic acid-conjugated DSPE-PEG liposomes for targeted therapy of ulcerative colitis
- 24 Jun 2026
- Journal of Drug Targeting
Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment
- 22 Jun 2026
- Journal of Drug Targeting
Eletriptan HBr Loaded Solid Lipid Nanoparticle Integrated Microneedles: A Targeted and Minimally Invasive Approach for Migraine Management
- 17 Jun 2026
- Journal of Drug Targeting
Nanomaterials for Subcellular Organelle Targeting: Unlocking New Avenues for Enhanced Therapeutic Effectiveness
- 17 Jun 2026
- Journal of Drug Targeting
Carbonic anhydrase modulation in the tumour microenvironment: synergistic pathways with oncolytic viruses in gastrointestinal malignancies
- 16 Jun 2026
- Journal of Drug Targeting
Tubulin as a Well-Established Yet Underexploited Target: New Opportunities for Drugs Repurposing?
- 29 Jun 2026
- Journal of drug targeting
Physcion-loaded, folic acid-conjugated DSPE-PEG liposomes for targeted therapy of ulcerative colitis
- 24 Jun 2026
- Journal of Drug Targeting
Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment
- 22 Jun 2026
- Journal of Drug Targeting
Eletriptan HBr Loaded Solid Lipid Nanoparticle Integrated Microneedles: A Targeted and Minimally Invasive Approach for Migraine Management
- 17 Jun 2026
- Journal of Drug Targeting
Nanomaterials for Subcellular Organelle Targeting: Unlocking New Avenues for Enhanced Therapeutic Effectiveness
- 17 Jun 2026
- Journal of Drug Targeting
Carbonic anhydrase modulation in the tumour microenvironment: synergistic pathways with oncolytic viruses in gastrointestinal malignancies
- 16 Jun 2026
- Journal of Drug Targeting